Stay updated with breaking news from Devan Bloch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
People who gained immunity -; either through vaccination or exposure -; against the original strain of SARS-CoV-2, the virus that causes COVID-19, also are likely to have some protection against the pathogen's omicron variant.
A prospective study by Johns Hopkins Medicine researchers demonstrates that convalescent plasma (shown here) – a blood product collected from patients
Nationwide, multicenter clinical trial led by Johns Hopkins shows convalescent plasma works as an early treatment for COVID-19, reducing need for hospitalization by 50%
Researchers at Johns Hopkins Medicine and Johns Hopkins Bloomberg School of Public Health put convalescent plasma to the test in June 2020 to see if it could help keep COVID patients out of the hospital.
A physician removes a bag of donated COVID-19 convalescent plasma after thawing. A study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg